Sat, Apr 19, 2014, 12:42 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Navidea Biopharmaceuticals, Inc Message Board

neoncrush69 1 post  |  Last Activity: Mar 7, 2014 4:24 PM Member since: Apr 14, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Per Thomas Tulip,

    "Lymphoseek revenue to Navidea more than doubled from third to fourth quarters, growing to approximately $342,000 -- $343,000. In 2014 through February, we are already well ahead of this number and it continues to grow. We remain convinced that fourth quarter '13 revenue, and that's which we are booking in the first quarter of '14, our steps along the path we previously articulate. We may not -- we maintained our projection that Lymphoseek will reach a majority market share in the next 10 to 14 months."

    Sales are going up, we have a strong balance sheet and great pipeline...milestones to hit soon, this is a must-have stock! GLTA!

    Sentiment: Strong Buy

NAVB
1.660.00(0.00%)Apr 17 4:06 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Rayonier Inc.
NYSEThu, Apr 17, 2014 4:03 PM EDT